Generic Name: Canakinumab
Brand Name: Ilaris
Manufacturer: Novartis Pharmaceuticals Inc.
Indications: Systemic juvenile idiopathic arthritis
Submission Type: New Indication
Project Status: Complete
Date Recommendation Issued: June 17, 2016
Recommendation Type: Reimburse with clinical criteria and/or conditions